Treprostinil
Treprostinil is a pharmaceutical drug with 17 clinical trials. Currently 1 active trials ongoing. Historical success rate of 76.9%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
4
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.9%
10 of 13 finished
23.1%
3 ended early
1
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension
A Study to Observe the Safety, Tolerability, and Efficacy of Remodulin
Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
Clinical Trials (17)
Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension
A Study to Observe the Safety, Tolerability, and Efficacy of Remodulin
Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
Safety and Efficacy of Treprostinil in Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplantation
A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus
Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension
Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation
Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH
Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
Acute Effects of Inhaled Treprostinil in Fontan Patients
A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants
Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
Cutaneous Iontophoresis of Iloprost and Treprostinil in Healthy Volunteers
All 17 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 17